Real-time sensing of MAPK signaling in medulloblastoma cells reveals cellular evasion mechanism counteracting dasatinib blockade of ERK activation during invasion
Open Access
- 1 October 2020
- Vol. 22 (10) , 470-483
Abstract
No abstract availableKeywords
Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNF_31003A_165860/1)
- Krebsliga Schweiz (KLS-3834-02-2016)
- Universität Zürich
- Foundation for Research in Science and the Humanities (STWF-17-03)
This publication has 43 references indexed in Scilit:
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- Oncogenic KRAS and BRAF activation of the MEK/ERK signaling pathway promotes expression of dual-specificity phosphatase 4 (DUSP4/MKP2) resulting in nuclear ERK1/2 inhibitionOncogene, 2012
- Cooperation between c-Met and Focal Adhesion Kinase Family Members in Medulloblastoma and Implications for TherapyMolecular Cancer Therapeutics, 2012
- Antitumor effect in medulloblastoma cells by gefitinib: Ectopic HER2 overexpression enhances gefitinib effects in vivoNeuro-Oncology, 2009
- Identification and Characterization of a General Nuclear Translocation Signal in Signaling ProteinsMolecular Cell, 2008
- Blebs lead the way: how to migrate without lamellipodiaNature Reviews Molecular Cell Biology, 2008
- Cell motility through plasma membrane blebbingJournal of Cell Biology, 2008
- Overriding Imatinib Resistance with a Novel ABL Kinase InhibitorScience, 2004
- Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysisNature Cell Biology, 2003
- Compensation mechanism in tumor cell migrationJournal of Cell Biology, 2003